119 related articles for article (PubMed ID: 20858106)
1. Expression of interleukin-17 in autoimmune dacryoadenitis in MRL/lpr mice.
Jie G; Jiang Q; Rui Z; Yifei Y
Curr Eye Res; 2010 Oct; 35(10):865-71. PubMed ID: 20858106
[TBL] [Abstract][Full Text] [Related]
2. Th1 versus Th2 immune responses in autoimmune lacrimal gland disease in MRL/Mp mice.
Jabs DA; Lee B; Whittum-Hudson JA; Prendergast RA
Invest Ophthalmol Vis Sci; 2000 Mar; 41(3):826-31. PubMed ID: 10711700
[TBL] [Abstract][Full Text] [Related]
3. The role of Fas-Fas ligand-mediated apoptosis in autoimmune lacrimal gland disease in MRL/MpJ mice.
Jabs DA; Lee B; Whittum-Hudson J; Prendergast RA
Invest Ophthalmol Vis Sci; 2001 Feb; 42(2):399-401. PubMed ID: 11157873
[TBL] [Abstract][Full Text] [Related]
4. Cytokines in autoimmune lacrimal gland disease in MRL/MpJ mice.
Jabs DA; Prendergast RA; Rorer EM; Hudson AP; Whittum-Hudson JA
Invest Ophthalmol Vis Sci; 2001 Oct; 42(11):2567-71. PubMed ID: 11581200
[TBL] [Abstract][Full Text] [Related]
5. Absence of 4 1BB gene function exacerbates lacrimal gland inflammation in autoimmune-prone MRL-Faslpr mice.
Vinay DS; Kim JD; Asai T; Choi BK; Kwon BS
Invest Ophthalmol Vis Sci; 2007 Oct; 48(10):4608-15. PubMed ID: 17898284
[TBL] [Abstract][Full Text] [Related]
6. Genetic dissociation of dacryoadenitis and sialadenitis in a Sjogren's syndrome mouse model with common and different susceptibility gene loci.
Kamao T; Miyazaki T; Soga Y; Komori H; Terada M; Ohashi Y; Nose M
Invest Ophthalmol Vis Sci; 2009 Jul; 50(7):3257-65. PubMed ID: 19218603
[TBL] [Abstract][Full Text] [Related]
7. Autoimmune Th2-mediated dacryoadenitis in MRL/MpJ mice becomes Th1-mediated in IL-4 deficient MRL/MpJ mice.
Jabs DA; Prendergast RA; Campbell AL; Lee B; Akpek EK; Gérard HC; Hudson AP; Whittum-Hudson JA
Invest Ophthalmol Vis Sci; 2007 Dec; 48(12):5624-9. PubMed ID: 18055812
[TBL] [Abstract][Full Text] [Related]
8. High incidence of autoimmune dacryoadenitis in male non-obese diabetic (NOD) mice depending on sex steroid.
Takahashi M; Ishimaru N; Yanagi K; Haneji N; Saito I; Hayashi Y
Clin Exp Immunol; 1997 Sep; 109(3):555-61. PubMed ID: 9328136
[TBL] [Abstract][Full Text] [Related]
9. Suppressive effect of a traditional Japanese medicine, Hachimi-jio-gan (Ba-Wei-Di-Huang-Wan), on the hyperresponsiveness to IL-18 in autoimmune MRL/MPJ-lpr/lpr mice.
Furuya Y; Kawakita T; Nomoto K
Int Immunopharmacol; 2003 Mar; 3(3):365-73. PubMed ID: 12639814
[TBL] [Abstract][Full Text] [Related]
10. Cyclosporine therapy suppresses ocular and lacrimal gland disease in MRL/Mp-lpr/lpr mice.
Jabs DA; Lee B; Burek CL; Saboori AM; Prendergast RA
Invest Ophthalmol Vis Sci; 1996 Feb; 37(2):377-83. PubMed ID: 8603842
[TBL] [Abstract][Full Text] [Related]
11. Histologic examination of the NOD-mouse lacrimal glands, a potential model for idiopathic autoimmune dacryoadenitis in Sjogren's syndrome.
Moore PA; Bounous DI; Kaswan RL; Humphreys-Beher MG
Lab Anim Sci; 1996 Feb; 46(1):125-8. PubMed ID: 8699811
[No Abstract] [Full Text] [Related]
12. Impact of gender on exocrine gland inflammation in mouse models of Sjögren's syndrome.
Toda I; Sullivan BD; Rocha EM; Da Silveira LA; Wickham LA; Sullivan DA
Exp Eye Res; 1999 Oct; 69(4):355-66. PubMed ID: 10504269
[TBL] [Abstract][Full Text] [Related]
13. Antagonist of interferon-inducible protein 10/CXCL10 ameliorates the progression of autoimmune sialadenitis in MRL/lpr mice.
Hasegawa H; Inoue A; Kohno M; Muraoka M; Miyazaki T; Terada M; Nakayama T; Yoshie O; Nose M; Yasukawa M
Arthritis Rheum; 2006 Apr; 54(4):1174-83. PubMed ID: 16575871
[TBL] [Abstract][Full Text] [Related]
14. Murine models of Sjögren's syndrome. Evolution of the lacrimal gland inflammatory lesions.
Jabs DA; Enger C; Prendergast RA
Invest Ophthalmol Vis Sci; 1991 Feb; 32(2):371-80. PubMed ID: 1993589
[TBL] [Abstract][Full Text] [Related]
15. Leakage of aquaporin 5 in the tear of dacryoadenitis mice.
Hirai S; Ishida N; Watanabe K; Mita S
Invest Ophthalmol Vis Sci; 2000 Aug; 41(9):2432-7. PubMed ID: 10937550
[TBL] [Abstract][Full Text] [Related]
16. In vivo role of IL-10 and IL-12 during development of Sjögren's syndrome in MRL/lpr mice.
Yanagi K; Haneji N; Hamano H; Takahashi M; Higashiyama H; Hayashi Y
Cell Immunol; 1996 Mar; 168(2):243-50. PubMed ID: 8640871
[TBL] [Abstract][Full Text] [Related]
17. Inflammatory mediators in autoimmune lacrimal gland disease in MRL/Mpj mice.
Jabs DA; Gérard HC; Wei Y; Campbell AL; Hudson AP; Akpek EK; Lee B; Prendergast RA; Whittum-Hudson JA
Invest Ophthalmol Vis Sci; 2004 Jul; 45(7):2293-8. PubMed ID: 15223808
[TBL] [Abstract][Full Text] [Related]
18. Tumor necrosis factor inhibitor gene expression suppresses lacrimal gland immunopathology in a rabbit model of autoimmune dacryoadenitis.
Zhu Z; Stevenson D; Schechter JE; Mircheff AK; Crow RW; Atkinson R; Ritter T; Bose S; Trousdale MD
Cornea; 2003 May; 22(4):343-51. PubMed ID: 12792478
[TBL] [Abstract][Full Text] [Related]
19. Submandibular and lacrimal gland immunoglobulin in the C3H.MRL-Faslpr autoimmune mouse model of Sjögren's syndrome.
Trune DR; Leedy DA
Laryngoscope; 1998 Nov; 108(11 Pt 1):1729-32. PubMed ID: 9818834
[TBL] [Abstract][Full Text] [Related]
20. Ca2+ signaling by cholinergic and alpha1-adrenergic agonists is up-regulated in lacrimal and submandibular glands in a murine model of Sjögren's syndrome.
Zoukhri D; Hodges RR; Rawe IM; Dartt DA
Clin Immunol Immunopathol; 1998 Nov; 89(2):134-40. PubMed ID: 9787115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
